Imagine Eyes appoints Maelys Bellay as QA/RA specialist

Maelys Bellay recently joined our Quality Assurance and Regulatory Affairs (QA/RA) team at Imagine Eyes. “I am happy to…

Imagine Eyes to meet pharmas to speed up the development of therapies

To accelerate the clinical development of new retinal treatments, we propose to implement advanced retinal imaging technology…

Deciphering AMD: cellular phenotyping & short term progression

Interview & discussion with 3 ophthalmology professors about the use of AO retinal imaging in dry AMD.

Retinal adaptive optics imaging goes multimodal

A publication in Nature Scientific Reports introduces a technology that delivers multimodal multiscale retinal images, developed by MERLIN - a collaborative project uniting Imagine Eyes, 3 academic teams and 2 clinical centers. It received financial support from the European Commission's Horizon 2020 program.

Great presentations at the rtx1 users’ e-symposium 2022! Replay available

Last week, we had the pleasure to host the rtx1 users’ e-symposium 2022, chaired by Prof. Paulo E. Stanga from The Retina Clinic London, and Dr. Daniela Bacherini from AOU Careggi Teaching Hospital in Florence.

Imagine Eyes laureate of NEXT French Healthcare

We are happy to share that Imagine Eyes has been selected for NEXT French Healthcare, an acceleration program dedicated…

ARVO 2022 – New retinal findings with Imagine Eyes’ AO imaging

At ARVO 2022, users of Imagine Eyes’ adaptive optics (AO) imaging systems will present new clinical findings in several retinal diseases, myopia, as well as multiple sclerosis. They will report on cellular phenotypes, structure-function relations, and surgical outcomes assessed at the cellular level.

H2020 MERLIN project celebrates successful final review

At Imagine Eyes we are happy to announce the successful completion of our Horizon 2020 MERLIN project. We received a very…

i2eye meeting – Innovative Imaging in Eye Disease

Users of Imagine Eyes' adaptive optics retinal imaging systems will present 11 talks about phenotyping and monitoring of diseases in the retina...

Euretina 2021 – Progression rate of retinitis pigmentosa measured over 6 months

Researchers at the Lions Eye Institute present a longitudinal study that assessed the progression of RP with both OCT and rtx1...